|
Features
|
n
|
CFL-1 IHC score, n (%)
|
χ2
value
|
P-valuea
|
|---|
|
Low
|
High
|
|---|
|
Gender
|
|
Male
|
23
|
10(43.4)
|
13(56.6)
|
0.208
|
0.648
|
|
Female
|
26
|
13(50)
|
13(50)
| | |
|
Age at surgery (years)
|
|
≥ 65
|
27
|
11(40.7)
|
16(59.3)
|
0.927
|
0.335
|
|
< 65
|
22
|
12(54.5)
|
10(45.5)
| | |
|
Localization
|
|
Colon ascendens
|
14
|
3(21.4)
|
11(78.6)
|
6.381
|
0.09
|
|
Colon descendens
|
10
|
5(50)
|
5(50)
| | |
|
Colon transversum
|
3
|
1(33.3)
|
2(66.7)
| | |
|
Colon sigmoideum/rectum
|
22
|
14(63.6)
|
8(36.4)
| | |
|
Tumor type
|
|
Adenocarcinoma
|
40
|
20(50)
|
20(50)
|
0.819
|
0.364
|
|
Adenocarcinoma/mucinous
|
9
|
3(33.3)
|
6(66.7)
| | |
|
Tumor grade
|
|
Well differentiated
|
1
|
1 (100)
|
0
|
1.355
|
0.508
|
|
Moderately differentiated
|
45
|
21(46.6)
|
24(53.4)
| | |
|
Poorly differentiated
|
3
|
1(33.3)
|
2(66.7)
| | |
|
T stage (AJCC)
|
|
T1/2
|
15
|
10(66.7)
|
5(33.3)
|
7.985
|
0.001**
|
|
T3
|
16
|
3(18.7)
|
13(81.3)
| | |
|
T4
|
18
|
10(55.5)
|
8(44.5)
| | |
|
Lymph node metastasis
|
|
Present
|
19
|
5(26.3)
|
14(73.7)
|
5.299
|
0.02*
|
|
Absent
|
30
|
18(60)
|
12(40)
| | |
|
Liver metastasis
|
|
Present
|
13
|
7(53.8)
|
6(46.2)
|
0.339
|
0.560
|
|
Absent
|
36
|
16(44.4)
|
20(55.6)
| | |
|
Lymphovascular invasion
|
|
Present
|
13
|
7(53.8)
|
6(46.2)
|
0.339
|
0.560
|
|
Absent
|
36
|
16(44.4)
|
20(55.6)
| | |
|
Perineural invasion
|
|
Present
|
11
|
6(54.5)
|
5(45.6)
|
0.329
|
0.565
|
|
Absent
|
38
|
17(44.7)
|
21(55.3)
| | |
|
Tumor size (cm3
)
|
|
≥ 33
|
24
|
10(41.7)
|
14(58.3)
|
0.525
|
0.468
|
|
< 33
|
25
|
13(52)
|
12(48)
| | |
-
aP value obtained from χ2 test
- CRC colorectal cancer, AJCC American Joint Committee on Cancer
